GlassScriptPhysician profile
Olivia Mcdonald
NPI 1023649746
$6,142.45
in general payments reported to CMS, 2019-2025
39 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,934 · 2022: $1,649 · 2023: $1,010 · 2024: $1,153 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,559.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,089.62 | 2021-2025 | |
| Novo Nordisk INC | $444.70 | 2021-2024 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $405.79 | 2021-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $393.85 | 2021-2024 | Mounjaro, Lyumjev |
| Pfizer INC. | $376.36 | 2021-2025 | |
| Noven Therapeutics, LLC | $373.84 | 2023-2025 | Xelstrym |
| Sunovion Pharmaceuticals INC. | $339.52 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $267.45 | 2021-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $258.00 | 2022-2024 | |
| Amgen INC. | $244.38 | 2023-2025 | Krystexxa, Prolia, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $231.99 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $155.45 | 2021-2024 | Breztri |
| Supernus Pharmaceuticals, INC. | $135.65 | 2022-2023 | Qelbree |
| Astellas Pharma US INC | $133.51 | 2021-2023 | Myrbetriq |
| Corcept Therapeutics | $112.68 | 2021-2025 | Korlym |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.